Vivani Medical (NASDAQ:VANI - Get Free Report) is expected to be releasing its Q2 2025 earnings data before the market opens on Tuesday, August 12th. Analysts expect Vivani Medical to post earnings of ($0.09) per share for the quarter.
Vivani Medical (NASDAQ:VANI - Get Free Report) last posted its quarterly earnings results on Tuesday, May 13th. The company reported ($0.11) earnings per share for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.01). On average, analysts expect Vivani Medical to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Vivani Medical Stock Performance
Shares of NASDAQ VANI traded up $0.02 during mid-day trading on Friday, reaching $1.38. The company had a trading volume of 35,469 shares, compared to its average volume of 197,852. Vivani Medical has a twelve month low of $0.91 and a twelve month high of $1.80. The stock has a market capitalization of $81.75 million, a PE ratio of -3.21 and a beta of 2.99. The stock's 50 day moving average is $1.33 and its 200-day moving average is $1.18.
Wall Street Analyst Weigh In
Separately, HC Wainwright restated a "buy" rating and set a $4.00 price target on shares of Vivani Medical in a report on Monday, May 19th.
Read Our Latest Research Report on VANI
About Vivani Medical
(
Get Free Report)
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Featured Stories
Before you consider Vivani Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vivani Medical wasn't on the list.
While Vivani Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
